You are here » Home » Companies » Company Overview » Glaxosmithkline Pharma Ltd

Glaxosmithkline Pharma Ltd.

BSE: 500660 Sector: Health care
NSE: GLAXO ISIN Code: INE159A01016
BSE LIVE 15:40 | 05 May 3597.35 -25.90
(-0.71%)
OPEN

3610.00

HIGH

3612.95

LOW

3559.10

NSE LIVE 15:31 | 05 May 3609.40 -18.30
(-0.50%)
OPEN

3627.20

HIGH

3628.95

LOW

3556.25

OPEN 3610.00
PREVIOUS CLOSE 3623.25
VOLUME 243
52-Week high 3850.00
52-Week low 3035.65
P/E 79.20
Mkt Cap.(Rs cr) 30469.55
Buy Price 3597.35
Buy Qty 1.00
Sell Price 0.00
Sell Qty 0.00
OPEN 3610.00
CLOSE 3623.25
VOLUME 243
52-Week high 3850.00
52-Week low 3035.65
P/E 79.20
Mkt Cap.(Rs cr) 30469.55
Buy Price 3597.35
Buy Qty 1.00
Sell Price 0.00
Sell Qty 0.00

About Glaxosmithkline Pharma Ltd.

Glaxosmithkline Pharma Ltd

GlaxoSmithKline Pharma Ltd is one of the world's leading research-based pharmaceutical and healthcare companies. The company's product portfolio includes prescription medicines and vaccines. Their prescription medicines range across therapeutic areas, such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases. They also offer a range of v...> More

Glaxosmithkline Pharma Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   30,470
EPS - TTM () [*S] 45.42
P/E Ratio (X) [*S] 79.20
Face Value ()   10
Latest Dividend (%)   625.00
Latest Dividend Date 23 Jul 2015
Dividend Yield (%) 1.74
Book Value / Share () [*S] 240.97
P/B Ratio () [*S] 14.93
[*C] Consolidated     [*S] Standalone

Glaxosmithkline Pharma Ltd - Financial Results

Particulars ( cr) Dec 2015 Dec 2014 % Chg
Net Sales 735.59 650.86 13.02
Other Income 26.47 37.77 -29.92
Total Income 762.06 688.63 10.66
Total Expenses 629.32 582.26 8.08
Operating Profit 132.74 106.37 24.79
Net Profit 79.9 45.3 76.38
Equity Capital 84.7 84.7 -
> More on Glaxosmithkline Pharma Ltd Financials Results

Glaxosmithkline Pharma Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Aurobindo Pharma 805.20 -0.89 47120.30
Cipla 541.20 1.47 43482.71
Cadila Health. 322.65 0.12 33029.68
Glaxosmit Pharma 3597.35 -0.71 30469.55
Divi's Lab. 1044.15 -0.75 27716.96
Torrent Pharma. 1399.75 -0.30 23686.57
Glenmark Pharma. 815.65 -0.55 23017.64
> More on Glaxosmithkline Pharma Ltd Peer Group

Glaxosmithkline Pharma Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 75.00
Banks/FIs 8.03
FIIs 2.25
Insurance 0.00
Mutual Funds 1.67
Indian Public 11.99
Custodians 0.00
Other 1.05
> More on Glaxosmithkline Pharma Ltd Share Holding Pattern

Glaxosmithkline Pharma Ltd - Research Reports

Date Broker Action Price Report
02/11 Angel Broking Neutral 3295 PDF IconDetails
06/08 Angel Broking Neutral 3746 PDF IconDetails
13/08 Angel Broking Neutral 2513 PDF IconDetails
> More on Glaxosmithkline Pharma Ltd Research Reports

Glaxosmithkline Pharma Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -4.17% -3.66% -1.33% -1.42%
1 Month -2.73% -2.60% 1.52% 1.74%
3 Month 9.32% 9.17% 2.62% 3.29%
6 Month 12.75% 12.47% -3.96% -2.76%
1 Year 11.42% 11.56% -7.94% -7.08%
3 Year 58.07% 58.38% 29.05% 30.14%

Glaxosmithkline Pharma Ltd - STOCK STRENGTH

Today's Low/High 3559.10
3612.95
Week Low/High 3544.85
3785.00
Month Low/High 3544.85
3806.00
YEAR Low/High 3035.65
3850.00
All TIME Low/High 25.75
3850.00
Widgets Magazine
Widgets Magazine
Widgets Magazine

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard